細胞単離/細胞分離の世界市場予測（～2024年）...市場調査レポートについてご紹介

TABLE OF CONTENTS

1 INTRODUCTION 21
1.1 OBJECTIVES OF THE STUDY 21
1.2 MARKET DEFINITION 21
1.2.1 MARKETS COVERED 22
1.2.2 COUNTRY COVERAGE 23
1.2.3 YEARS CONSIDERED FOR THE STUDY 23
1.3 CURRENCY 24
1.4 LIMITATIONS 24
1.5 STAKEHOLDERS 24
2 RESEARCH METHODOLOGY 25
2.1 SECONDARY DATA 26
2.1.1 KEY DATA FROM SECONDARY SOURCES 26
2.2 PRIMARY DATA 27
2.2.1 KEY DATA FROM PRIMARY SOURCES 28
2.3 MARKET SIZE ESTIMATION 29
2.3.1 BOTTOM-UP APPROACH 29
2.3.2 TOP-DOWN APPROACH 30
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 31
2.5 ASSUMPTIONS FOR THE STUDY 32
3 EXECUTIVE SUMMARY 33
4 PREMIUM INSIGHTS 39
4.1 CELL ISOLATION: MARKET OVERVIEW 39
4.2 NORTH AMERICA: CELL ISOLATION MARKET, BY PRODUCT (2018) 40
4.3 GEOGRAPHICAL SNAPSHOT OF THE CELL ISOLATION MARKET 41
5 MARKET OVERVIEW 42
5.1 INTRODUCTION 42
5.2 MARKET DYNAMICS 42
5.2.1 DRIVERS 43
5.2.1.1 Increasing government funding for cell-based research 43
5.2.1.2 Increasing number of patients suffering from cancer and infectious diseases 44
5.2.1.3 Technological advancements 45
5.2.1.4 Growing focus on personalized medicine 45
5.2.2 RESTRAINTS 46
5.2.2.1 Ethical issues related to embryonic stem cell isolation 46
5.2.2.2 High cost of cell-based research 46
5.2.3 OPPORTUNITIES 47
5.2.3.1 Emerging markets 47
6 CELL ISOLATION MARKET, BY PRODUCT 48
6.1 INTRODUCTION 49
6.2 CONSUMABLES 50
6.2.1 REAGENTS, KITS, MEDIA, AND SERA 51
6.2.1.1 Owing to the disposable nature of reagents and assay kits, this market is driven by their consistent usage and frequent purchases 51
6.2.2 BEADS 52
6.2.2.1 Growing demand for magnetic beads in T-cell and stem cell isolation is a major factor driving growth in this product segment 52
6.2.3 DISPOSABLES 52
6.2.3.1 Increasing investments in research by governments and companies are a major factor boosting the growth of the cell isolation disposables market 52
6.3 INSTRUMENTS 53
6.3.1 CENTRIFUGES 54
6.3.1.1 Growing use of centrifuges in the pharma-biotech industry and multi-functionality options offered by these instruments are driving the growth of this product segment 54
6.3.2 FLOW CYTOMETERS 55
6.3.2.1 Launch of innovative and cost-effective flow cytometers is likely to drive the growth of the market 55
6.3.3 MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS 56
6.3.4 FILTRATION SYSTEMS 56
6.3.4.1 Increasing research activities in cell biology to boost the market 56
7 CELL ISOLATION MARKET, BY CELL TYPE 58
7.1 INTRODUCTION 59
7.2 HUMAN CELLS 60
7.2.1 DIFFERENTIATED CELLS 61
7.2.1.1 Growing investments by market players to develop new and innovative products is expected to support the growth of the differentiated cell isolation market 61
7.2.2 STEM CELLS 62
7.2.2.1 Rising government initiatives focused on supporting stem cell research expected to drive market growth 62
7.3 ANIMAL CELLS 63
7.3.1 BIOPHARMACEUTICAL COMPANIES ARE THE MAJOR END USERS OF ISOLATED ANIMAL CELLS 63
 
8 CELL ISOLATION MARKET, BY CELL SOURCE 64
8.1 INTRODUCTION 65
8.2 BONE MARROW 66
8.2.1 A NUMBER OF BONE MARROW-DERIVED STEM CELLS HAVE BEEN COMMERCIALIZED IN THE LAST DECADE 66
8.3 ADIPOSE TISSUE 67
8.3.1 ADIPOSE STEM/STROMAL CELLS CAN GENERATE A VARIETY OF OTHER CELL TYPES 67
8.4 CORD BLOOD/EMBRYONIC STEM CELLS 68
8.4.1 MARKET GROWTH IS DRIVEN BY THE HIGH THERAPEUTIC POTENCY OF THESE STEM CELLS 68
9 CELL ISOLATION MARKET, BY TECHNIQUE 69
9.1 INTRODUCTION 70
9.2 CENTRIFUGATION-BASED CELL ISOLATION 71
9.2.1 COST-EFFECTIVENESS OF THIS TECHNIQUE IN BOTH SMALL-SCALE AND LARGE-SCALE OPERATIONS—A MAJOR DRIVER 71
9.3 SURFACE MARKER-BASED CELL ISOLATION 72
9.3.1 WIDE USAGE OF THIS TECHNIQUE IN BIOPHARMACEUTICAL AND BIOTECH INDUSTRIES IS A MAJOR REASON FOR THE GROWTH OF THIS MARKET 72
9.4 FILTRATION-BASED CELL ISOLATION 73
9.4.1 THE MAJOR FACTOR DRIVING THE GROWTH OF THIS MARKET SEGMENT IS THE LOW COST OF THE FILTRATION TECHNIQUE 73
10 CELL ISOLATION MARKET, BY APPLICATION 74
10.1 INTRODUCTION 75
10.2 BIOMOLECULE ISOLATION 76
10.2.1 BIOMOLECULE ISOLATION DOMINATES THE CELL ISOLATION APPLICATIONS MARKET 76
10.3 CANCER RESEARCH 77
10.3.1 HIGH DISEASE INCIDENCE HAS FUELLED THE DEMAND FOR ADVANCED TREATMENT 77
10.4 STEM CELL RESEARCH 78
10.4.1 INCREASING FUNDING IN STEM CELL RESEARCH TO SUPPORT MARKET GROWTH 78
10.5 TISSUE REGENERATION & REGENERATIVE MEDICINE 79
10.5.1 FUNDING FOR REGENERATIVE MEDICINE INITIATIVES HAS RISEN 79
10.6 IN VITRO DIAGNOSTICS 80
10.6.1 RISING DISEASE INCIDENCE HAS DRIVEN DEMAND FOR INNOVATIVE THERAPIES AND DIAGNOSTICS 80
 
11 CELL ISOLATION MARKET, BY END USER 81
11.1 INTRODUCTION 82
11.2 BIOTECHNOLOGY & BIOPHARMACEUTICAL COMPANIES 83
11.2.1 FAVORABLE INVESTMENTS HAVE BOOSTED OVERALL PACE OF RESEARCH 83
11.3 RESEARCH LABORATORIES & INSTITUTES 84
11.3.1 RISING FUNDING FOR CELL-BASED RESEARCH TO DRIVE MARKET GROWTH 84
11.4 HOSPITALS & DIAGNOSTIC LABORATORIES 85
11.4.1 INCREASING NUMBER OF HOSPITALS IN EMERGING COUNTRIES WILL CONTRIBUTE TO MARKET GROWTH 85
11.5 OTHER END USERS 86
12 CELL ISOLATION MARKET, BY REGION 87
12.1 INTRODUCTION 88
12.2 NORTH AMERICA 89
12.2.1 US 94
12.2.1.1 US to witness the highest growth in the North American cell isolation market due to the increasing government funding on cell-based research 94
12.2.2 CANADA 98
12.2.2.1 Increasing funding for research in regenerative medicine to support market growth in Canada 98
12.3 EUROPE 101
12.3.1 GERMANY 105
12.3.1.1 Germany to be fastest-growing market for cell isolation in Europe 105
12.3.2 FRANCE 109
12.3.2.1 Increasing prevalence of various chronic and infectious diseases to drive market growth 109
12.3.3 UK 113
12.3.3.1 Government investments in stem cell research to drive the market for cell isolation in the UK 113
12.3.4 ITALY 116
12.3.4.1 Increasing number of cell biology seminars and conferences to fuel the adoption of cell isolation products 116
12.3.5 SPAIN 120
12.3.5.1 Increasing funding from private and public organizations to aid market growth 120
12.3.6 REST OF EUROPE (ROE) 124
12.4 ASIA PACIFIC 128
12.4.1 JAPAN 132
12.4.1.1 Increasing geriatric population and substantial rise in the prevalence of chronic diseases will drive the market 132
12.4.2 CHINA 136
12.4.2.1 Cell therapy-based research is growing in China 136
 
12.4.3 INDIA 140
12.4.3.1 Rising incidence of chronic and infectious disease to drive demand for cell isolation products 140
12.4.4 REST OF ASIA PACIFIC 145
12.5 ROW 148
12.5.1 LATIN AMERICA 152
12.5.1.1 Rising incidence of chronic and infectious diseases will boost the market during the forecast period 152
12.5.2 MIDDLE EAST AND AFRICA 156
12.5.2.1 Increasing availability of funds will support the market in the MEA 156
13 COMPETITIVE LANDSCAPE 160
13.1 OVERVIEW 160
13.2 MARKET RANKING ANALYSIS, 2017 161
13.3 KEY STRATEGIES 162
13.3.1 PRODUCT LAUNCHES, 2015–2018 162
13.3.2 EXPANSIONS, 2015–2018 162
13.3.3 PARTNERSHIPS, 2015–2018 162
13.3.4 ACQUISITIONS, 2015–2018 162
13.4 COMPETITIVE LEADERSHIP MAPPING (2017) 163
13.4.1 VANGUARDS 163
13.4.2 INNOVATORS 163
13.4.3 DYNAMIC PLAYERS 163
13.4.4 EMERGING PLAYERS 163
13.5 COMPETITIVE LEADERSHIP MAPPING FOR START-UPS (2017) 165
13.5.1 PROGRESSIVE COMPANIES 165
13.5.2 STARTING BLOCKS 165
13.5.3 RESPONSIVE COMPANIES 165
13.5.4 DYNAMIC COMPANIES 165
 
14 COMPANY PROFILES 167
(Business Overview, Products Offered, Recent Developments, MnM View)*
14.1 THERMO FISHER SCIENTIFIC, INC. 167
14.2 BECTON, DICKINSON AND COMPANY 169
14.3 BECKMAN COULTER INC. (SUBSIDIARY OF DANAHER CORPORATION) 172
14.4 MERCK KGAA 174
14.5 TERUMO BCT (SUBSIDIARY OF TERUMO CORPORATION) 177
14.6 GE HEALTHCARE 179
14.7 BIO-RAD LABORATORIES, INC. 181
14.8 MILTENYI BIOTEC 183
14.9 PLURISELECT LIFE SCIENCE UG (HAFTUNGSBESCHRÄNKT) & CO. KG 185
14.10 STEMCELL TECHNOLOGIES, INC. 186
*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.
15 APPENDIX 187
15.1 INSIGHTS OF INDUSTRY EXPERTS 187
15.2 DISCUSSION GUIDE 188
15.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 192
15.4 AVAILABLE CUSTOMIZATIONS 194
15.5 RELATED REPORTS 194
15.1 AUTHOR DETAILS 195